A laboratory for validating cancer biomarkers
Official title: Biomarker Reference Laboratory
Funded at Johns Hopkins University · NIH-10890730 · Data updated 2026-11-12
This study is looking to improve how we test for prostate cancer and decide on treatments by developing new, non-invasive tests that can help identify how aggressive the cancer is and monitor patients who are being watched closely, so that you can get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 20, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $247,738 |
| NIH project number | 5U2CCA271895-02 |
| Project ID | NIH-10890730 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include men diagnosed with prostate cancer who are considering active surveillance or are currently under such management.
✕Less likely to help
Patients with non-prostate cancers or those who are not candidates for active surveillance may not benefit from this research.
What this research studies
This research focuses on the validation of biomarkers for prostate cancer, aiming to improve diagnostic methods and treatment decisions. The laboratory at Johns Hopkins will develop and refine assays to assess cancer aggressiveness and monitor patients under active surveillance. By utilizing advanced technologies in proteomics and bioinformatics, the project seeks to create non-invasive tests that can help identify patients at risk of disease progression. Patients may benefit from more accurate assessments and tailored treatment options based on these biomarkers.
Why it matters
Potential benefit: If successful, this research could lead to more precise and personalized treatment strategies for prostate cancer patients.
How similar studies have gone: Previous research has shown success in biomarker validation for cancer diagnostics, indicating a promising approach in this area.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Chan, Daniel Wanyui — Johns Hopkins University
- Study coordinator: Chan, Daniel Wanyui
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Accelerated flap coverage for severe leg injuries: earlier reconstruction vs standard timing
This study tests whether doing early flap coverage after a severe leg injury lowers infection risk and improves healing for patients with open wounds and bone injury.
-
Placebo-controlled shunting for iNPH: does the surgery help with walking and balance?
A doctor-led trial at Johns Hopkins will test whether a shunt surgery improves walking and balance in older adults with idiopathic normal pressure hydrocephalus.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Johns Hopkins Total Worker Health Center focusing on mental health
A nationwide center at Johns Hopkins is working to improve mental health and well-being among workers by studying workplace health strategies and translating findings into practical tools.
-
Role of fat droplets in liver fat and inflammatory signals in NAFLD
A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.